Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Главный автор: | Khandker, Tahia Anjum |
---|---|
Другие авторы: | Kabir, Eva Rahman |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2024
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/22046 |
Схожие документы
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
по: Islam, Nahidul
Опубликовано: (2023) -
Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
по: Mahin, Md. Tamjidur Rahman
Опубликовано: (2024) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
по: Afroza, Halima
Опубликовано: (2024) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
по: Bishakha, Adwiza Chakraborty
Опубликовано: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
по: Meem, Manila
Опубликовано: (2023)